Therapeutics targeting the metastatic breast cancer bone microenvironment

CL Ihle, SJ Wright-Hobart, P Owens - Pharmacology & Therapeutics, 2022 - Elsevier
Breast cancer (BC) patient prognosis has improved over the past 2 decades with a 99% 5-
year survival rate for localized BC, yet metastatic breast cancer (mBC) continues to cause …

[HTML][HTML] Hepatectomy, RFA, and other liver directed therapies for treatment of breast cancer liver metastasis: a systematic review

K Rivera, DR Jeyarajah, K Washington - Frontiers in Oncology, 2021 - frontiersin.org
Background The liver is the second most common site of breast cancer metastasis. Liver
directed therapies including hepatic resection, radiofrequency ablation (RFA), transarterial …

[HTML][HTML] Resection of liver metastases from breast cancer: a multicentre analysis

X He, Q Zhang, Y Feng, Z Li, Q Pan, Y Zhao… - Clinical and …, 2020 - Springer
Background Surgery is becoming more practical and effective than conservative treatment in
improving the poor outcomes of patients with breast cancer liver metastasis (BCLM) …

[HTML][HTML] Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: a systematic review and meta-analysis

Y Xiao, B Zhang, Y Wu - Journal of Zhejiang University. Science. B, 2018 - ncbi.nlm.nih.gov
Objective: To evaluate the comparative therapeutic efficacy of radiofrequency ablation (RFA)
and hepatic resection (HR) for breast cancer liver metastases (BCLMs). Methods: Studies …

Systematic review of early and long-term outcome of liver resection for metastatic breast cancer: Is there a survival benefit?

TG Yoo, I Cranshaw, R Broom, S Pandanaboyana… - The Breast, 2017 - Elsevier
Background Isolated liver metastases occur rarely in patients with metastatic breast cancer.
The success of liver resection (LR) for other metastatic disease has led centres to explore …

Transarterial chemoembolisation for breast cancer with liver metastasis: A systematic review

M Wang, J Zhang, S Ji, G Shao, K Zhao, Z Wang, A Wu - The Breast, 2017 - Elsevier
Background There is limited data on the impact of transarterial chemoembolisation (TACE)
on survival in patients of breast cancer with liver metastasis (BCLM). Methods A systematic …

A population-based study on liver metastases in women with newly diagnosed breast cancer

J Xie, Z Xu - Cancer Epidemiology, Biomarkers & Prevention, 2019 - AACR
Background: Population-based estimates for prognosis among patients with liver
metastases in newly diagnosed breast cancer are not generally available. Methods: Within …

[HTML][HTML] Surgical treatment of breast cancer liver metastases-A nationwide registry-based case control study

M Sundén, C Hermansson, H Taflin… - European Journal of …, 2020 - Elsevier
Introduction The benefit of liver resection or ablation for breast cancer liver metastases
(BCLM) remains unclear. The aim of the study was to determine survival after isolated BCLM …

[HTML][HTML] A nomogram for predicting survival in patients with breast cancer liver metastasis: a population-based study

Y Xiong, X Shi, Q Hu, X Wu, E Long, Y Bian - Frontiers in oncology, 2021 - frontiersin.org
Objective The prognosis of patients with breast cancer liver metastasis (BCLM) was poor.
We aimed at constructing a nomogram to predict overall survival (OS) for BCLM patients …

The safety and effectiveness of liver resection for breast cancer liver metastases: A systematic review

K Fairhurst, L Leopardi, T Satyadas, G Maddern - The Breast, 2016 - Elsevier
Breast cancer liver metastases have traditionally been considered incurable and any
treatment given therefore palliative. Liver resections for breast cancer metastases are being …